We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

72 hedge funds and large institutions have $273M invested in Albireo Pharma Inc in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 26 increasing their positions, 20 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

40% more capital invested

Capital invested by funds: $195M → $273M (+$78.2M)

30% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 20

6% more funds holding

Funds holding: 68 → 72 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

53% less call options, than puts

Call options by funds: $193K | Put options by funds: $412K

Holders
72
Holders Change
+4
Holders Change %
+5.88%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
26
Reduced
20
Closed
1
Calls
$193K
Puts
$412K
Net Calls
-$219K
Net Calls Change
-$170K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.57M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$3.59M
3
ACH
ArrowMark Colorado Holdings
Colorado
+$1.3M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.17M
5
MWNA
Marshall Wace North America
New York
+$682K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.64M
2
Renaissance Technologies
Renaissance Technologies
New York
-$358K
3
Morgan Stanley
Morgan Stanley
New York
-$332K
4
BlackRock
BlackRock
New York
-$304K
5
Victory Capital Management
Victory Capital Management
Texas
-$236K
Name Holding Trade Value Shares
Change 		Change in
Stake
Allianz Asset Management
26
Allianz Asset Management
Germany
$1.17M -$15.3K -570 -2%
Prudential Financial
27
Prudential Financial
New Jersey
$953K +$81.6K +3,031 +11%
William Blair & Company
28
William Blair & Company
Illinois
$940K +$45.1K +1,677 +6%
AA
29
ALPS Advisors
Colorado
$931K +$33.7K +1,253 +5%
MWNA
30
Marshall Wace North America
New York
$816K +$682K +25,344 New
Renaissance Technologies
31
Renaissance Technologies
New York
$787K -$358K -13,284 -35%
PPA
32
Parametric Portfolio Associates
Washington
$747K -$27.5K -1,023 -4%
Man Group
33
Man Group
United Kingdom
$701K +$586K +21,771 New
Charles Schwab
34
Charles Schwab
California
$659K +$36.1K +1,341 +7%
KCM
35
Kennedy Capital Management
Missouri
$650K +$543K +20,174 New
TA
36
Teachers Advisors
New York
$634K – – –
EP
37
Eversept Partners
New York
$581K – – –
TCIM
38
TIAA CREF Investment Management
New York
$572K +$2.64K +98 +0.6%
PC
39
PA Capital
Virginia
$490K +$13.6K +506 +3%
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$460K – – –
JMH
41
J.M. Hartwell
New York
$459K +$57.9K +2,150 +18%
Wells Fargo
42
Wells Fargo
California
$418K +$8.53K +317 +3%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$416K -$4.04K -150 -1%
State of Wisconsin Investment Board
44
State of Wisconsin Investment Board
Wisconsin
$396K +$75.4K +2,800 +29%
Deutsche Bank
45
Deutsche Bank
Germany
$365K -$14.1K -524 -4%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$329K – – –
AAP
47
Ardsley Advisory Partners
Connecticut
$245K -$67.3K -2,500 -25%
M&T Bank
48
M&T Bank
New York
$201K +$168K +6,225 New
AIG
49
American International Group
New York
$187K -$5.06K -188 -3%
Acadian Asset Management
50
Acadian Asset Management
Massachusetts
$164K -$62.6K -2,326 -31%
1
2
3

ALBO Hedge Fund Activity: Q1 2019 in Review

72 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q1 2019, worth a combined $273M — up 40% from $195M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ALBO positions and 1 closed out — a net gain of 4 holders — while 26 added to existing stakes and 20 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $4.57M. The largest seller was Fidelity Investments, cutting an estimated $1.64M.

  • 72 institutional investors held Albireo Pharma Inc (ALBO) as of Q1 2019, up from 68 in Q4 2018.
  • Funds reported $273M of Albireo Pharma Inc stock for Q1 2019, up 40% quarter-over-quarter.
  • 5 funds opened new Albireo Pharma Inc positions in Q1 2019 and 1 closed out, a net change of +4 holders.
  • The largest Albireo Pharma Inc buyer in Q1 2019 was Point72 Asset Management, an estimated $4.57M added.
  • The largest Albireo Pharma Inc seller in Q1 2019 was Fidelity Investments, an estimated $1.64M sold.

Based on aggregated 13F filings for Q1 2019.